Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk

Дата публикации: 01-08-2026 00:00:00

This systematic review and meta-analysis evaluates the safety and efficacy of abbreviated dual antiplatelet therapy durations in patients at high bleeding risk undergoing percutaneous coronary intervention.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Prasugrel—The Default P2Y12 Inhibitor After PCI for ACS?	0	7.98	01-08-2026
2	Catheter-Based LAAC vs OAC in Patients With AF	0	13.15	26-08-2026
3	Intravenous Thrombolysis Beyond Conventional Time Window for Acute Ischemic Stroke	0	10.94	06-08-2026
4	Interpreting the APERITIF Randomized Clinical Trial	0	13.07	01-08-2026
5	Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke	0	7	13-07-2026
6	Interpreting the APERITIF Randomized Clinical Trial—Reply	0	10.38	01-08-2026
7	Exercise Performance With Aficamten vs Metoprolol in oHCM	0	6.05	01-08-2026
8	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
9	Right Ventricular Metrics as End Points in Clinical Trials	0	5.8	01-08-2026
10	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026

Классификация: Мнения. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.22. Источник: archderm.jamanetwork.com.